Wang S, Xiao L
Int J Mol Sci. 2025; 26(5).
PMID: 40076831
PMC: 11899905.
DOI: 10.3390/ijms26052213.
Calvo B, Schembri-Wismayer P, Duran-Alonso M
Cells. 2025; 14(5).
PMID: 40072076
PMC: 11898746.
DOI: 10.3390/cells14050347.
Kang B, Murphy M, Ng C, Leventhal M, Huynh N, Im E
bioRxiv. 2025; .
PMID: 40027702
PMC: 11870572.
DOI: 10.1101/2025.02.19.639023.
Simmons D, Selvaraj S, Chen T, Cao G, Camelo T, McHugh T
Mol Ther Methods Clin Dev. 2025; 33(1):101415.
PMID: 39995448
PMC: 11848452.
DOI: 10.1016/j.omtm.2025.101415.
Blumenstock S, Arakelyan D, Del Grosso N, Schneider S, Shao Y, Gjoni E
bioRxiv. 2025; .
PMID: 39974900
PMC: 11839025.
DOI: 10.1101/2025.02.07.637155.
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System.
Hegde A, Timm L, Sivley C, Ramiyaramcharankarthic S, Lowrimore O, Hendrix B
Int J Mol Sci. 2025; 26(3).
PMID: 39940735
PMC: 11817509.
DOI: 10.3390/ijms26030966.
Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases.
Garcia F, Heiman M
Mol Neurodegener. 2025; 20(1):13.
PMID: 39881338
PMC: 11780804.
DOI: 10.1186/s13024-025-00799-z.
Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in .
Tortajada-Perez J, Carranza A, Trujillo-Del Rio C, Collado-Perez M, Millan J, Garcia-Garcia G
Antioxidants (Basel). 2025; 14(1).
PMID: 39857412
PMC: 11762898.
DOI: 10.3390/antiox14010078.
Identifying time patterns in Huntington's disease trajectories using dynamic time warping-based clustering on multi-modal data.
Giannoula A, De Paepe A, Sanz F, Furlong L, Camara E
Sci Rep. 2025; 15(1):3081.
PMID: 39856140
PMC: 11759715.
DOI: 10.1038/s41598-025-86686-5.
Lipidomics of Huntington's Disease: A Comprehensive Review of Current Status and Future Directions.
Yilmaz A, Akyol S, Ashrafi N, Saiyed N, Turkoglu O, Graham S
Metabolites. 2025; 15(1).
PMID: 39852353
PMC: 11766911.
DOI: 10.3390/metabo15010010.
A Pilot Proteomic Analysis of Huntington's Disease by Functional Capacity.
McGarry A, Moaddel R
Brain Sci. 2025; 15(1.
PMID: 39851443
PMC: 11764106.
DOI: 10.3390/brainsci15010076.
Comparisons of neurodegenerative disease biomarkers across different biological fluids from patients with Huntington's disease.
Bamford A, Parkin G, Corey-Bloom J, Thomas E
J Neurol. 2025; 272(2):158.
PMID: 39849121
PMC: 11759467.
DOI: 10.1007/s00415-024-12785-4.
In vivo CRISPR-Cas9 genome editing in mice identifies genetic modifiers of somatic CAG repeat instability in Huntington's disease.
Mouro Pinto R, Murtha R, Azevedo A, Douglas C, Kovalenko M, Ulloa J
Nat Genet. 2025; 57(2):314-322.
PMID: 39843658
PMC: 11821541.
DOI: 10.1038/s41588-024-02054-5.
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review.
De Cleene N, Schwarzova K, Labrecque S, Cerejo C, Djamshidian A, Seppi K
Front Neurosci. 2025; 18():1505029.
PMID: 39840019
PMC: 11747286.
DOI: 10.3389/fnins.2024.1505029.
Engineering a membrane protein chaperone to ameliorate the proteotoxicity of mutant huntingtin.
Oh J, Catherine C, Kim E, Min K, Chan Jeong H, Kim H
Nat Commun. 2025; 16(1):737.
PMID: 39824813
PMC: 11742450.
DOI: 10.1038/s41467-025-56030-6.
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disease.
Handsaker R, Kashin S, Reed N, Tan S, Lee W, McDonald T
Cell. 2025; 188(3):623-639.e19.
PMID: 39824182
PMC: 11822645.
DOI: 10.1016/j.cell.2024.11.038.
Estimating disease onset distribution functions in mutation carriers with censored mixture data.
Ma Y, Wang Y
J R Stat Soc Ser C Appl Stat. 2025; 63(1):1-23.
PMID: 39823047
PMC: 11736984.
DOI: 10.1111/rssc.12025.
Total functioning capacity scale in Huntington's disease: natural course over time.
van der Zwaan K, Feleus S, Dekkers O, Roos R, de Bot S
J Neurol. 2025; 272(2):140.
PMID: 39812810
PMC: 11735551.
DOI: 10.1007/s00415-024-12771-w.
RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington's disease models.
Lin Y, Li C, Chen Y, Gao J, Li J, Huang C
Mol Neurodegener. 2025; 20(1):4.
PMID: 39806441
PMC: 11727607.
DOI: 10.1186/s13024-024-00794-w.
Targeting the epigenome with advanced delivery strategies for epigenetic modulators.
Guha S, Jagadeesan Y, Pandey M, Mittal A, Chitkara D
Bioeng Transl Med. 2025; 10(1):e10710.
PMID: 39801754
PMC: 11711227.
DOI: 10.1002/btm2.10710.